Skip to main content
. 2021 Dec 16;13(12):659–672. doi: 10.4253/wjge.v13.i12.659

Table 1.

Demographic and clinical features of the study population, n (%)

Characteristics
High volume (n = 871)
Low volume (n = 944)
P value1
Age 61.2 ± 14.3 60.1 ± 14.6 0.092
Male sex 463 (53.2) 448 (47.5) 0.0153
Split-dose 389 (44.7) 361 (38.2) 0.0063
High-definition colonoscope 296 (33.9) 310 (32.8) 0.605
Indication
Symptoms 538 (61.8) 563 (59.6)
Surveillance < 0.0013
Post polypectomy 134 (15.4) 154 (16.3)
Post colonic resection for CRC 73 (8.4) 73 (7.7)
Positive FBT 94 (10.8) 57 (6.1)
IBD 32 (3.6) 97 (10.3)
BMI, mean ± SD2 25.5 ± 4.3 25.0 ± 4.0 0.0153
Previous abdominal surgery 98 (11.3) 96 (10.2) 0.456
Constipation 66 (7.6) 86 (9.1) 0.239
Comorbidities
Heart disease 90 (10.3) 65 (6.9) 0.0093
Diabetes 72 (8.3) 65 (6.9) 0.266
Stroke/dementia 19 (2.2) 25 (2.6) 0.518
Severe CKD 21 (2.4) 15 (1.6) 0.209
Cirrhosis 12 (1.4) 13 (1.4) 0.999
GERD 192 (22.0) 219 (23.2) 0.557
Waiting time > 1 mo 485 (55.7) 570 (60.4) 0.0903
Non-adherence to low fiber diet 91 (10.5) 112 (11.9) 0.329
Lives alone2 123 (14.8) 149 (16.3) 0.395
Low instruction2 157 (19.6) 122 (14.1) 0.0023
1

P value degrees of freedom = 1, except for age (1814), indication (4) and body mass index (BMI) (1726).

2

BMI available for 1727 patients; information about living alone available for 1747 patients; instruction level available for 1662 patients.

3

Significant different.

CRC: Colorectal cancer; FBT: Fecal blood test; IBD: Inflammatory bowel disease; BMI: Body mass index; CKD: Chronic kidney disease; GERD: Gastroesophageal reflux disease.